Philip O. Livingston is CHIEF SCIENCE OFFICER at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX). They have made 1 open-market trade across 1 company since 2018, most recently 2018-01-12.
CIK 0001612050
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MBVX | 293,581 | $338K |
Shares reported on the most recent Form 4, priced at the 2018-01-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBVX | SELL | 2018-01-10 | 2018-01-16 | $0.97 | $36K | -14.5% | -25.5% | -46.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.